PRESS RELEASE >

Ceva Animal Health renews its shareholding structure with all its long-standing partners and opens its capital to Mérieux Institute and ARCHIMED to accelerate its growth.

PRESS RELEASE >

Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health

Press release >

World Animal Vaccination Day: Ceva emphasizes the benefits of preventive medicine

Fundraising for animals! >

During the year, we support several organizations that deal with animals and do priority work.

Award winning Ceva stand! >

We are happy to share the news that at the HVG job fair held between October 4-6, 2023, Ceva won the 1st prize for the most attractive stand in the 9-16 sqm category.

New General Manager at the head of Ceva-Phylaxia >

As part of this transformation, with effect from 13.06.2023, Dr. Tamás Szamkó took over the position of General Manager of Ceva-Phlyaxia Zrt.

Major new investment announced to develop 2nd vaccine production site in Hungary >

Ceva continues to deliver double-digit growth >

Libourne 24th July 2017 - Consolidated sales of the Ceva Group reached €546m at the end of June 2017, representing growth of 20% versus last year and +6.6% at constant perimeter and exchange rates.

Ceva Phylaxia inaugurates state of the art vaccine plant to support “Innovation with Impact” growth plan >

Budapest, Hungary, July : Ceva Santé Animale, one of the fastest growing, top 10 animal healthcare companies today held the inauguration ceremony of its new European vaccine production facility

Ceva reinforces its position in china and swine through new joint-venture with EBVAC >

In the presence of the Chinese Prime Minister, Li Keqiang and French Prime Minister, Bernard Cazeneuve, Ceva Santé Animale (Ceva) and EBVAC today signed a joint-venture agreement to create a new business, Ceva EBVAC, focused on the swine sector.